U.S. Stock News

NasdaqGS:THFF
NasdaqGS:THFFBanks

US Market's Undiscovered Gems Three Promising Small Caps

As the U.S. market grapples with rising Treasury yields and a cautious Federal Reserve outlook, small-cap stocks are navigating a landscape marked by both challenges and opportunities. In this environment, identifying promising small caps requires a keen eye for companies with robust fundamentals that can weather economic fluctuations and capitalize on niche market demands.
NYSEAM:NBY
NYSEAM:NBYPharmaceuticals

Assessing NovaBay Pharmaceuticals (NBY) Valuation After Digital Asset Financing And SKY Token Treasury Shift

NovaBay Pharmaceuticals (NBY) has reshaped its story with a private placement of pre funded warrants totaling about US$134 million, largely paid in digital assets, and a pivot toward a SKY token focused treasury model. See our latest analysis for NovaBay Pharmaceuticals. The financing news comes after a very sharp 30 day share price return of 178.68% and a very large 1 year total shareholder return, although the 3 and 5 year total shareholder returns are still deeply negative, so long term...
NasdaqGS:ANNX
NasdaqGS:ANNXBiotechs

Annexon (ANNX) Is Up 15.6% After EMA Filing For GBS Antibody Tanruprubart Has The Bull Case Changed?

Annexon, Inc. recently submitted a Marketing Authorization Application to the European Medicines Agency for tanruprubart, a first-in-class antibody targeting complement-driven inflammation in Guillain-Barre syndrome, supported by randomized Phase 3 data and ongoing FORWARD study observations. This move underscores Annexon’s focus on severe neuroinflammatory diseases with limited treatment options, aiming to position tanruprubart as a potential new standard of care in GBS. We’ll now examine...
NasdaqGS:NAVI
NasdaqGS:NAVIConsumer Finance

Navient’s CFO and Oversight Shake-Up Might Change The Case For Investing In Navient (NAVI)

In early January 2026, Navient Corporation reshaped its leadership structure, appointing long-time executive Steve Hauber as Executive Vice President, Chief Financial Officer and Principal Accounting Officer, while Joe Fisher exited the CFO role and began a short transition period before leaving the company. By consolidating finance, legal, risk management, internal audit, and compliance under Hauber and expanding COO Troy Standish’s remit to technology and human resources, Navient is...
NYSE:PAR
NYSE:PARSoftware

Should Winning Papa Johns as Core AI Platform Partner Require Action From PAR Technology (PAR) Investors?

Papa Johns previously announced it selected PAR Technology’s PAR POS and PAR OPS platforms to underpin its next-generation U.S. in-restaurant technology stack, replacing legacy on-premise systems and targeting a fully rolled-out deployment across all domestic corporate and franchise locations by the end of 2027. This deal reinforces PAR’s role as an integrated restaurant tech provider, embedding its AI-enabled platform at scale within a major quick-service pizza chain’s operations and...
NYSE:THS
NYSE:THSFood

Will FMR’s Sharp Stake Cut Test Investor Confidence in TreeHouse Foods’ (THS) Efficiency Execution Narrative?

On December 31, 2025, FMR LLC sharply cut its holdings in TreeHouse Foods Inc, reducing its position by 2,718,583 shares while retaining 822,158 shares and a 1.60% stake. This sizeable pullback by a major institutional investor brings fresh attention to TreeHouse Foods’ ability to execute its efficiency plans amid ongoing market and operational challenges. We’ll now examine how FMR LLC’s large reduction in its TreeHouse stake interacts with the existing investment narrative and risk...
NasdaqGM:SPRY
NasdaqGM:SPRYBiotechs

Assessing ARS Pharmaceuticals (SPRY) Valuation After China Community Approval For Neffy Epinephrine Spray

China approval puts focus on ARS Pharmaceuticals’ new market opportunity ARS Pharmaceuticals (SPRY) is back on investor radar after partner Pediatrix Therapeutics received approval from China’s National Medical Products Association for community use of neffy, its intranasal epinephrine spray. This decision makes neffy the first government approved epinephrine product for use outside Chinese hospitals. It creates a fresh addressable market and sets up ARS to collect regulatory milestone...
NasdaqCM:MVST
NasdaqCM:MVSTMachinery

Do Microvast Holdings’ (MVST) New Finance Leaders Signal a Shift in Its Capital Allocation Priorities?

Microvast Holdings recently strengthened its finance leadership, appointing Rodney Worthen as Chief Financial Officer and hiring former NextDecade executive Eric N. Garcia as Chief Accounting Officer, both effective in early January 2026. These appointments bring a blend of corporate finance, investor relations, and Big Four audit experience that could influence how Microvast manages reporting quality, capital allocation, and future expansion decisions. Next, we’ll examine how bringing in a...
NYSE:EGY
NYSE:EGYOil and Gas

A Look At VAALCO Energy (EGY) Valuation After Strong 2025 Outlook And Etame Drilling Results

VAALCO Energy (EGY) is drawing attention after reporting full year 2025 production and sales volumes around the midpoint and top of guidance, alongside encouraging drilling results at its Etame complex offshore Gabon. See our latest analysis for VAALCO Energy. The production and sales update lands after a strong run in the share price, with a 7 day share price return of 23.29% and a 30 day share price return of 31.20%. The 5 year total shareholder return of 136.12% points to momentum that has...
NasdaqCM:ABTC
NasdaqCM:ABTCSoftware

American Bitcoin (ABTC) Valuation After New Bitcoin Reserves Disclosure And Bitcoin Yield Metric Launch

American Bitcoin’s new disclosure focus American Bitcoin (ABTC) is drawing fresh attention after highlighting more than 5,098 Bitcoin in reserves and rolling out a Bitcoin Yield Metric aimed at giving investors clearer insight into changes in its holdings. See our latest analysis for American Bitcoin. That renewed focus on its 5,098 Bitcoin reserves and the new Bitcoin Yield Metric comes after a tough period, with American Bitcoin’s share price return declining 67.78% over 90 days and 7.87%...
NYSE:BH.A
NYSE:BH.AHospitality

Assessing Biglari Holdings (BH.A) Valuation After Strong Recent Share Price Momentum

What recent performance suggests about Biglari Holdings (BH.A) Recent trading in Biglari Holdings (BH.A) has drawn attention, with the stock showing double digit returns over the past week, month, and past 3 months, prompting investors to reassess what is driving sentiment. See our latest analysis for Biglari Holdings. At a share price of $2,378.72, Biglari Holdings has seen a rapid shift in sentiment, with a 30 day share price return of 35.78% and a 1 year total shareholder return of...